To include your compound in the COVID-19 Resource Center, submit it here.

Iniparib: Additional Phase II data

Additional data from a single-arm, open-label, U.S. Phase II trial in 40 evaluable patients showed that IV BSI-201

Read the full 189 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE